• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Type 2 diabetes

Biolinq wearable on inside forearm
MedTech

Biolinq raises $100M to carry glucose sensor patch to the FDA

Biolinq's coin-sized device, worn on the forearm, can also track sleep and activity data to help provide additional metabolic data.
Conor Hale Apr 22, 2025 12:00pm
Eli Lilly

Lilly's oral GLP-1 delivers Ozempic-like efficacy in phase 3

Apr 17, 2025 6:45am
Dexcom G7 CGM

Dexcom survey shows providers opt for tech over drugs in Type 2

Mar 19, 2025 12:20pm
Tandem Diabetes Care Mobi insulin pump

FDA clears Tandem Diabetes insulin-dosing algorithm in Type 2

Feb 25, 2025 2:01pm
Inside the small intestine

Fractyl pivots T2D therapy to obesity & GLP-1s, lays off staff

Jan 31, 2025 11:45am
concept of computer chip and dollar sign

Novo bets $190M near-term on AI pact in obesity, diabetes

Jan 8, 2025 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings